Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (84)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhou, Y.-X.
Right arrow Articles by Deng, C.-X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y.-X.
Right arrow Articles by Deng, C.-X.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 13 2001-2008
© 2000 Oxford University Press

A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures

Yong-Xing Zhou, Xiaoling Xu, Lin Chen, Cuiling Li, Steven G. Brodie and Chu-Xia Deng+

Genetics of Development and Disease Branch, NIDDK, NIH, 10/9N105, 10 Center Drive, Bethesda, MD 20892, USA

Pfeiffer syndrome is a classic form of craniosynostosis that is caused by a proline->arginine substitution at amino acid 252 (Pro252Arg) in fibroblast growth factor receptor 1 (FGFR1). Here we show that mice carrying a Pro250Arg mutation in Fgfr1, which is orthologous to the Pfeiffer syndrome mutation in humans, exhibit anterio-posteriorly shortened, laterally widened and vertically heightened neurocraniums. Analysis of the posterior and anterior frontal, sagittal and coronal sutures of early post-natal mutant mice revealed premature fusion. The sutures of mutant mice had accelerated osteoblast proliferation and increased expression of genes related to osteoblast differentiation, suggesting that bone formation at the sutures is locally increased in Pfeiffer syndrome. Of note, dramatically increased expression of core-binding transcription factor {alpha} subunit type 1 (Cbfa1) accompanied premature fusion, suggesting that Cbfa1 may be a downstream target of Fgf/Fgfr1 signals. This was confirmed in vitro, where we demonstrate that transfection with wild-type or mutant Fgfr1 induces Cbfa1 expression. The induced expression was also observed using Fgf ligands (Fgf2 and Fgf8). These studies provide direct genetic evidence that the Pro252Arg mutation in FGFR1 causes human Pfeiffer syndrome and uncovers a molecular mechanism in which Fgf/Fgfr1 signals regulate intramembraneous bone formation by modulating Cbfa1 expression.

+ To whom correspondence should be addressed. Tel: +1 301 402 7225; Fax: +1 301 480 1135; Email: chuxiad@bdg10.niddk.nih.gov


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J.-M. Lin, K. E. Callon, J.-S. Lin, M. Watson, V. Empson, P. C. Tong, A. Grey, D. Naot, C. R. Green, I. R. Reid, et al.
Actions of fibroblast growth factor-8 in bone cells in vitro
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E142 - E150.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
J H D. Bassett and G. R Williams
The skeletal phenotypes of TR{alpha} and TR{beta} mutant mice
J. Mol. Endocrinol., April 1, 2009; 42(4): 269 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Tanaka, H. Sato, H. Doi, C. A. Yoshida, T. Shimizu, H. Matsui, M. Yamazaki, H. Akiyama, K. Kawai-Kowase, T. Iso, et al.
Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells
Mol. Cell. Biol., February 1, 2008; 28(3): 1147 - 1160.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
C. Li, D. A. Scott, E. Hatch, X. Tian, and S. L. Mansour
Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development
Development, January 1, 2007; 134(1): 167 - 176.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Aghaloo, C. M. Cowan, Y.-F. Chou, X. Zhang, H. Lee, S. Miao, N. Hong, S. Kuroda, B. Wu, K. Ting, et al.
Nell-1-Induced Bone Regeneration in Calvarial Defects
Am. J. Pathol., September 1, 2006; 169(3): 903 - 915.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E.-J. Jeon, K.-Y. Lee, N.-S. Choi, M.-H. Lee, H.-N. Kim, Y.-H. Jin, H.-M. Ryoo, J.-Y. Choi, M. Yoshida, N. Nishino, et al.
Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation
J. Biol. Chem., June 16, 2006; 281(24): 16502 - 16511.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. P. Valta, T. Hentunen, Q. Qu, E. M. Valve, A. Harjula, J. A. Seppanen, H. K. Vaananen, and P. L. Harkonen
Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8
Endocrinology, May 1, 2006; 147(5): 2171 - 2182.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Desai, M. E. Shannon, M. D. Johnson, D. W. Ruff, L. A. Hughes, M. K. Kerley, D. A. Carpenter, D. K. Johnson, E. M. Rinchik, and C. T. Culiat
Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects
Hum. Mol. Genet., April 15, 2006; 15(8): 1329 - 1341.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis
The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling
Development, January 1, 2006; 133(1): 63 - 74.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
R.T. Franceschi
Biological Approaches to Bone Regeneration by Gene Therapy
Journal of Dental Research, December 1, 2005; 84(12): 1093 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Guenou, K. Kaabeche, S. L. Mee, and P. J. Marie
A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome
Hum. Mol. Genet., June 1, 2005; 14(11): 1429 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Tanimoto, M. Yokozeki, K. Hiura, K. Matsumoto, H. Nakanishi, T. Matsumoto, P. J. Marie, and K. Moriyama
A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome
J. Biol. Chem., October 29, 2004; 279(44): 45926 - 45934.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. P. Eswarakumar, M. C. Horowitz, R. Locklin, G. M. Morriss-Kay, and P. Lonai
A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis
PNAS, August 24, 2004; 101(34): 12555 - 12560.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
M. K. Hajihosseini, M. D. Lalioti, S. Arthaud, H. R. Burgar, J. M. Brown, S. R. F. Twigg, A. O. M. Wilkie, and J. K. Heath
Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics
Development, January 15, 2004; 131(2): 325 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
O. A. Ibrahimi, F. Zhang, A. V. Eliseenkova, R. J. Linhardt, and M. Mohammadi
Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity
Hum. Mol. Genet., January 1, 2004; 13(1): 69 - 78.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-H. Lee, Y.-J. Kim, H.-J. Kim, H.-D. Park, A.-R. Kang, H.-M. Kyung, J.-H. Sung, J. M. Wozney, H.-J. Kim, and H.-M. Ryoo
BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-{beta}1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression
J. Biol. Chem., September 5, 2003; 278(36): 34387 - 34394.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
K. Yu, J. Xu, Z. Liu, D. Sosic, J. Shao, E. N. Olson, D. A. Towler, and D. M. Ornitz
Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth
Development, July 1, 2003; 130(13): 3063 - 3074.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-J. Kim, J.-H. Kim, S.-C. Bae, J.-Y. Choi, H.-J. Kim, and H.-M. Ryoo
The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2
J. Biol. Chem., January 3, 2003; 278(1): 319 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
D. M. Ornitz and P. J. Marie
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
Genes & Dev., June 15, 2002; 16(12): 1446 - 1465.
[Full Text] [PDF]

Home page
 Genes Dev.Home page
N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi, T. Fujimori, N. Itoh, and S. Takada
FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis
Genes & Dev., April 1, 2002; 16(7): 870 - 879.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
J. A. Montero, Y. Ganan, D. Macias, J. Rodriguez-Leon, J. J. Sanz-Ezquerro, R. Merino, J. Chimal-Monroy, M. A. Nieto, and J. M. Hurle
Role of FGFs in the control of programmed cell death during limb development
Development, June 1, 2001; 128(11): 2075 - 2084.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.